Skip to main content

MoneyWorks4Me

Evonile Pharma - Quaterly Results

05 Nov 2026 Evaluate
The sales slipped to Rs. 560.50 millions, down -37.95% for the September 2026 quarter as against Rs. 903.30 millions during the year-ago period.The Net Loss for the quarter ended September 2026 is Rs. -775.40 millions as compared to Net Profit of Rs. 242.20 millions of corresponding quarter ended September 2025Operating profit Margin for the quarter ended September 2026 slipped to -240.80% as compared to 332.80% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 560.50 903.30 -37.95 1598.60 1778.80 -10.13 3543.30 3562.70 -0.54
Other Income 77.40 94.00 -17.66 164.80 200.10 -17.64 387.70 419.60 -7.60
PBIDT -240.80 332.80 -172.36 195.70 711.30 -72.49 1328.70 1333.80 -0.38
Interest 48.30 1.10 4290.91 48.90 2.10 2228.57 12.60 7.70 63.64
PBDT -971.70 331.70 -392.95 -535.80 709.20 -175.55 1316.10 1326.10 -0.75
Depreciation 38.90 5.20 648.08 43.10 10.50 310.48 19.50 21.90 -10.96
PBT -1010.60 326.50 -409.53 -578.90 698.70 -182.85 1296.60 1304.20 -0.58
TAX -235.20 84.30 -379.00 -125.60 180.30 -169.66 364.80 295.20 23.58
Deferred Tax -120.60 -0.50 24020.00 -125.60 -0.50 25020.00 15.30 -4.40 -447.73
PAT -775.40 242.20 -420.15 -453.30 518.40 -187.44 931.80 1009.00 -7.65
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) -42.96 36.84 -216.61 12.24 39.99 -69.39 37.50 37.44 0.16
Peers
Company Name CMP
Redington 356.35
Adani Enterprises 2731.05
Amrapali Industries 34.31
Maxgrow India 175.85
Rashi Peripheral 864.95
View more..